Covid-19 Drug Remdesivir to Cost $3,120 for Typical Patient on Private Insurance – WSJ

Gilead Sciences disclosed its pricing plans as it prepares to begin charging for remdesivir in July. The U.S. has been distributing the drug donated by Gilead since it was authorized for emergency use in May.

Source: Covid-19 Drug Remdesivir to Cost $3,120 for Typical Patient on Private Insurance – WSJ


The article was originally published here!

Comments

Post a Comment

Popular posts from this blog

Today’s Top Stories: May 18, 2020

Image
Today’s Top Stories is brought to you by My Daily Grind News . The Lede Fired State Dept. watchdog was probing whether Pompeo made staffer walk dog, pick up laundry Editorial : In the Trump administration’s latest episode of “We say ‘drain the swamp,’ but we really mean ‘fill it with swampier people,'” it’s been suggested that the firing of Steve Linick, former State Department Inspector General, was politically motivated. The shock! You see, Linick had been investigating reports of Pompeo staff members running personal errands for the Secretary of State. Things such as picking up dry cleaning and walking the dog. What good is a cushy federal government job if you can’t have people feed you grapes while bathing you? Coronavirus (COVID-19) Worldwide: 4,737,299 confirmed infections 315,622 confirmed deaths US stats: 1,486,742 confirmed infections 89,564 confirmed deaths Source ...
Read more

Today’s Top Stories: March 27, 2020

Image
Coronavirus update: 558,552 infected, up from 495,086 yesterday. 25,251 deaths, up from 22,993 yesterday. New York is hardest hit, with Florida poised to claim largest death count (due to a large percentage of seniors who have retired there). Relevant COVID-19 stories: Live updates: British Prime Minister Boris Johnson tests positive for coronavirus; the U.S. now leads the world in confirmed cases Terrifying cellphone ‘heat map’ shows just how much people are still traveling Economy Update: DJIA is down nearly 900 points today, passing back down to the 21,000 range. The markets are awaiting a slew of really bad news. Relevant Economy stories: U.S. markets sharply turn after three straight days of gains America’s mortgage market sickens Politics: Senators voted 96-0 on the $2 Trillion federal fiscal stimulus package. The House votes Friday. Trump is expected to pass it. Teen Who Died of Covid-19 Was Denied Treatment...
Read more

Today’s Top Stories: April 24, 2020

Image
Today’s Top Stories is brought to you by My Daily Grind News . Coronavirus update: Source 2,735,117 confirmed infections, up from 2,649,680 yesterday. 192,019 confirmed deaths, up from 184,643 yesterday. Relevant COVID-19 stories: Will We Ever Return to Normal? How A Shortage Of Sand (And Other Common Items) Could Delay A Coronavirus Vaccine A 100-year-old WWII veteran dies of the coronavirus a century after the flu pandemic killed his twin Politics: Trump set to sign bill with nearly $500B more in virus aid Biden’s strength with older voters could threaten Trump’s electoral path in 2020 Phunware, a data firm for Trump campaign, got millions in coronavirus small business help Economy Update: Zoom’s stock surges toward a record after inclusion in the Nasdaq 100 Under Pressure, Chain to Return $20M US Loan Source The Dow is even, in the mid-23k range. Upcoming economic reports this week: Tuesday – Existing ho...
Read more